News

  • XplicoLOGO3

Summary Xplico Valuation Survey

November, 2018|0 Comments

In July and August 2018 Xplico conducted a survey among 600 industry professionals about valuation in the life science industry and received 79 responses. We hereby present the results of the survey.

PDF: Summary Xplico Valuation […]

  • Banner_OwnershipStructures

Xplico article for Biotech & Money / LSX

October, 2018|0 Comments

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech […]

  • Gazelle_Featured

Xplico named “a 2018 Gazelle Company” (a growth company) for the third year in a row by the leading Danish business newspaper Børsen.

October, 2018|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2018 Gazelle Company for the 3rd year in a row. Børsen analyses every year all the Danish companies to identify growth […]

  • Skærmbillede 2018-08-24 kl. 16.04.22

Xplico article for Biotech & Money / LSX

August, 2018|0 Comments

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team

August, 2018|0 Comments

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team as Executive Assistant and will be working closely together with the partners Uffe Boesen and Finn Nikolajsen.
Sisse holds a Master’s Degree in […]

  • LSX London February 5-6 2019

LSX World Congress, London, United Kingdom, February 5-6, 2019

August, 2018|0 Comments

LSX World Congress, London, United Kingdom, February 5-6, 2019

The LSX World Congress is a high-caliber, senior executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science executives need to […]

  • Austria_Vienna

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019

August, 2018|0 Comments

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019


Please meet us at the 2019 BIO-Europe Spring Partnering Conference in Vienna, Austria. With a focus on European innovation and global collaboration, BIO-Europe Spring is the […]

  • 1

Xplico Interview with Biotech & Money / LSX

July, 2018|0 Comments

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the […]

  • Xplico_Gazelle

Xplico named “a 2017 Gazelle Company” (a growth company) for the second year in a row by the leading Danish business newspaper Børsen.

February, 2018|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd year in a row. Børsen analyses every year all the Danish companies to identify growth […]

  • Xplico_Gazelle_2016

Xplico named “a 2016 Gazelle Company” (a growth company) by the leading Danish business newspaper Børsen.

January, 2017|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by […]

Xplico is pleased to announce that Peter Abelin has joined our valuation team.

January, 2017|0 Comments

Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience from the life science industry working with equity portfolio management, financial research and pharmaceutical development […]

Xplico launches Xplico Captable – a cap table providing simulations and waterfall analysis of the various stakeholders’ investments and values in a company.

January, 2017|0 Comments

Xplico Captable is a capitalization table providing simulations and waterfall analysis of the founders’ and investors’ percentage of ownership, equity dilution, and value of equity in connection with (potential) funding rounds and exits. Xplico Captable […]

  • Bi-Pharm-America-2019

Bio International Convention, Philadelphia, USA, June 3-6, 2019

September, 2014|0 Comments

Bio International Convention, Philadelphia, USA, June 3-6, 2019

Please meet us at the BIO International Convention in Philadelphia in June 2019. The key benefits of attending the Convention are access to global biotech and pharma leaders […]